Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 7, 2025

Primary Completion Date

June 30, 2029

Study Completion Date

June 30, 2029

Conditions
Long COVIDLong COVID SyndromeLong COVID-19 SyndromePASCPASC Post Acute Sequelae of COVID 19
Interventions
DEVICE

accelerated intermittent theta burst stimulation

Intermittent theta burst stimulation (iTBS), a FDA-approved form of noninvasive neuromodulation, can reduce neuropsychiatric symptoms and modulate inflammation in the thalamus as detected using dMRS, suggesting a potentially effective and efficient treatment approach with a pathophysiological component that is readily quantifiable.

Trial Locations (1)

87106

RECRUITING

University of New Mexico Health Science Center, Albuquerque

All Listed Sponsors
collaborator

The Mind Research Network

OTHER

collaborator

United States Department of Defense

FED

lead

University of New Mexico

OTHER

NCT06940609 - Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation | Biotech Hunter | Biotech Hunter